Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Oral Rabies Vaccine Market Insights, Forecast to 2029

Global Oral Rabies Vaccine Market Insights, Forecast to 2029

Industry: Pharma & Healthcare

Published: 2023-08-28

Pages: 77 Pages

Report ld: 1632783

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Global Oral Rabies Vaccine market is expected to reach to US$ 98 million in 2023, with a positive growth of %, compared with US$ 80 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Oral Rabies Vaccine industry is evaluated to reach US$ 297 million in 2029. The CAGR will be 20.3% during 2023 to 2029.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:
This report presents an overview of global Oral Rabies Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Oral Rabies Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted. 
Manufacturers, Type, Application and Regions Listed in the Report:

Report Metric
Details
Report Title
Global Oral Rabies Vaccine Market Insights, Forecast to 2029
Global Oral Rabies Vaccine Companies Covered
Boehringer Ingelheim(Merial), Ceva Santé Animale(Artemis Technologies), Virbac
Global Oral Rabies Vaccine Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Product definition, type and application introduction
Chapter 2: Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3: Manufacturers’ sales, revenue and price analysis, including manufacturers’ Oral Rabies Vaccine plant distribution, commercial date of Oral Rabies Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4: Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5: Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6: Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7: Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8: Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9: Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10: Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11: Manufacturers’ outline, covering company’s basic information, major business, Oral Rabies Vaccine introduction, etc. Oral Rabies Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12: Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13: Market opportunities and challenges analysis
Chapter 14: QYResearch’s Conclusions of Oral Rabies Vaccine
Chapter 15: Methodology and Data Sources adopted by QYResearch

Table of Contents

 1 Study Coverage
    1.1 Oral Rabies Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Oral Rabies Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
        1.2.2 Modified Live Virus
        1.2.3 Recombinant Vaccinia
        1.2.4 Recombinant Adenovirus Vaccine
    1.3 Market by Application
        1.3.1 Global Oral Rabies Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
        1.3.2 Government
        1.3.3 Commercial
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Executive Summary
    2.1 Global Oral Rabies Vaccine Sales Estimates and Forecasts 2018-2029
    2.2 Global Oral Rabies Vaccine Revenue by Region
        2.2.1 Global Oral Rabies Vaccine Revenue by Region: 2018 VS 2022 VS 2029
        2.2.2 Global Oral Rabies Vaccine Revenue by Region (2018-2023)
        2.2.3 Global Oral Rabies Vaccine Revenue by Region (2024-2029)
        2.2.4 Global Oral Rabies Vaccine Revenue Market Share by Region (2018-2029)
    2.3 Global Oral Rabies Vaccine Sales Estimates and Forecasts 2018-2029
    2.4 Global Oral Rabies Vaccine Sales by Region
        2.4.1 Global Oral Rabies Vaccine Sales by Region: 2018 VS 2022 VS 2029
        2.4.2 Global Oral Rabies Vaccine Sales by Region (2018-2023)
        2.4.3 Global Oral Rabies Vaccine Sales by Region (2024-2029)
        2.4.4 Global Oral Rabies Vaccine Sales Market Share by Region (2018-2029)
    2.5 US & Canada
    2.6 Europe
    2.7 China
    2.8 Asia (excluding China)
    2.9 Middle East, Africa and Latin America

 3 Competition by Manufactures
    3.1 Global Oral Rabies Vaccine Sales by Manufacturers
        3.1.1 Global Oral Rabies Vaccine Sales by Manufacturers (2018-2023)
        3.1.2 Global Oral Rabies Vaccine Sales Market Share by Manufacturers (2018-2023)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Rabies Vaccine in 2022
    3.2 Global Oral Rabies Vaccine Revenue by Manufacturers
        3.2.1 Global Oral Rabies Vaccine Revenue by Manufacturers (2018-2023)
        3.2.2 Global Oral Rabies Vaccine Revenue Market Share by Manufacturers (2018-2023)
        3.2.3 Global Top 10 and Top 5 Companies by Oral Rabies Vaccine Revenue in 2022
    3.3 Global Key Players of Oral Rabies Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
    3.4 Global Oral Rabies Vaccine Sales Price by Manufacturers
    3.5 Analysis of Competitive Landscape
        3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.5.2 Global Oral Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.6 Global Key Manufacturers of Oral Rabies Vaccine, Manufacturing Base Distribution and Headquarters
    3.7 Global Key Manufacturers of Oral Rabies Vaccine, Product Offered and Application
    3.8 Global Key Manufacturers of Oral Rabies Vaccine, Date of Enter into This Industry
    3.9 Mergers & Acquisitions, Expansion Plans

 4 Market Size by Type
    4.1 Global Oral Rabies Vaccine Sales by Type
        4.1.1 Global Oral Rabies Vaccine Historical Sales by Type (2018-2023)
        4.1.2 Global Oral Rabies Vaccine Forecasted Sales by Type (2024-2029)
        4.1.3 Global Oral Rabies Vaccine Sales Market Share by Type (2018-2029)
    4.2 Global Oral Rabies Vaccine Revenue by Type
        4.2.1 Global Oral Rabies Vaccine Historical Revenue by Type (2018-2023)
        4.2.2 Global Oral Rabies Vaccine Forecasted Revenue by Type (2024-2029)
        4.2.3 Global Oral Rabies Vaccine Revenue Market Share by Type (2018-2029)
    4.3 Global Oral Rabies Vaccine Price by Type
        4.3.1 Global Oral Rabies Vaccine Price by Type (2018-2023)
        4.3.2 Global Oral Rabies Vaccine Price Forecast by Type (2024-2029)

 5 Market Size by Application
    5.1 Global Oral Rabies Vaccine Sales by Application
        5.1.1 Global Oral Rabies Vaccine Historical Sales by Application (2018-2023)
        5.1.2 Global Oral Rabies Vaccine Forecasted Sales by Application (2024-2029)
        5.1.3 Global Oral Rabies Vaccine Sales Market Share by Application (2018-2029)
    5.2 Global Oral Rabies Vaccine Revenue by Application
        5.2.1 Global Oral Rabies Vaccine Historical Revenue by Application (2018-2023)
        5.2.2 Global Oral Rabies Vaccine Forecasted Revenue by Application (2024-2029)
        5.2.3 Global Oral Rabies Vaccine Revenue Market Share by Application (2018-2029)
    5.3 Global Oral Rabies Vaccine Price by Application
        5.3.1 Global Oral Rabies Vaccine Price by Application (2018-2023)
        5.3.2 Global Oral Rabies Vaccine Price Forecast by Application (2024-2029)

 6 US & Canada
    6.1 US & Canada Oral Rabies Vaccine Market Size by Type
        6.1.1 US & Canada Oral Rabies Vaccine Sales by Type (2018-2029)
        6.1.2 US & Canada Oral Rabies Vaccine Revenue by Type (2018-2029)
    6.2 US & Canada Oral Rabies Vaccine Market Size by Application
        6.2.1 US & Canada Oral Rabies Vaccine Sales by Application (2018-2029)
        6.2.2 US & Canada Oral Rabies Vaccine Revenue by Application (2018-2029)
    6.3 US & Canada Oral Rabies Vaccine Market Size by Country
        6.3.1 US & Canada Oral Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029
        6.3.2 US & Canada Oral Rabies Vaccine Sales by Country (2018-2029)
        6.3.3 US & Canada Oral Rabies Vaccine Revenue by Country (2018-2029)
        6.3.4 US
        6.3.5 Canada

 7 Europe
    7.1 Europe Oral Rabies Vaccine Market Size by Type
        7.1.1 Europe Oral Rabies Vaccine Sales by Type (2018-2029)
        7.1.2 Europe Oral Rabies Vaccine Revenue by Type (2018-2029)
    7.2 Europe Oral Rabies Vaccine Market Size by Application
        7.2.1 Europe Oral Rabies Vaccine Sales by Application (2018-2029)
        7.2.2 Europe Oral Rabies Vaccine Revenue by Application (2018-2029)
    7.3 Europe Oral Rabies Vaccine Market Size by Country
        7.3.1 Europe Oral Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029
        7.3.2 Europe Oral Rabies Vaccine Sales by Country (2018-2029)
        7.3.3 Europe Oral Rabies Vaccine Revenue by Country (2018-2029)
        7.3.4 Germany
        7.3.5 France
        7.3.6 U.K.
        7.3.7 Italy
        7.3.8 Russia

 8 China
    8.1 China Oral Rabies Vaccine Market Size
        8.1.1 China Oral Rabies Vaccine Sales  (2018-2029)
        8.1.2 China Oral Rabies Vaccine Revenue  (2018-2029)
    8.2 China Oral Rabies Vaccine Market Size by Application
        8.2.1 China Oral Rabies Vaccine Sales by Application (2018-2029)
        8.2.2 China Oral Rabies Vaccine Revenue by Application (2018-2029)

 9 Asia (excluding China)
    9.1 Asia Oral Rabies Vaccine Market Size by Type
        9.1.1 Asia Oral Rabies Vaccine Sales by Type (2018-2029)
        9.1.2 Asia Oral Rabies Vaccine Revenue by Type (2018-2029)
    9.2 Asia Oral Rabies Vaccine Market Size by Application
        9.2.1 Asia Oral Rabies Vaccine Sales by Application (2018-2029)
        9.2.2 Asia Oral Rabies Vaccine Revenue by Application (2018-2029)
    9.3 Asia Oral Rabies Vaccine Sales by Region
        9.3.1 Asia Oral Rabies Vaccine Revenue by Region: 2018 VS 2022 VS 2029
        9.3.2 Asia Oral Rabies Vaccine Revenue by Region (2018-2029)
        9.3.3 Asia Oral Rabies Vaccine Sales by Region (2018-2029)
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 China Taiwan
        9.3.7 Southeast Asia
        9.3.8 India

 10 Middle East, Africa and Latin America
    10.1 Middle East, Africa and Latin America Oral Rabies Vaccine Market Size by Type
        10.1.1 Middle East, Africa and Latin America Oral Rabies Vaccine Sales by Type (2018-2029)
        10.1.2 Middle East, Africa and Latin America Oral Rabies Vaccine Revenue by Type (2018-2029)
    10.2 Middle East, Africa and Latin America Oral Rabies Vaccine Market Size by Application
        10.2.1 Middle East, Africa and Latin America Oral Rabies Vaccine Sales by Application (2018-2029)
        10.2.2 Middle East, Africa and Latin America Oral Rabies Vaccine Revenue by Application (2018-2029)
    10.3 Middle East, Africa and Latin America Oral Rabies Vaccine Sales by Country
        10.3.1 Middle East, Africa and Latin America Oral Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029
        10.3.2 Middle East, Africa and Latin America Oral Rabies Vaccine Revenue by Country (2018-2029)
        10.3.3 Middle East, Africa and Latin America Oral Rabies Vaccine Sales by Country (2018-2029)
        10.3.4 Brazil
        10.3.5 Mexico
        10.3.6 Turkey
        10.3.7 Israel
        10.3.8 GCC Countries

 11 Company Profiles
    11.1 Boehringer Ingelheim(Merial)
        11.1.1 Boehringer Ingelheim(Merial) Company Information
        11.1.2 Boehringer Ingelheim(Merial) Overview
        11.1.3 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
        11.1.4 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Boehringer Ingelheim(Merial) Recent Developments
    11.2 Ceva Santé Animale(Artemis Technologies)
        11.2.1 Ceva Santé Animale(Artemis Technologies) Company Information
        11.2.2 Ceva Santé Animale(Artemis Technologies) Overview
        11.2.3 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
        11.2.4 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Ceva Santé Animale(Artemis Technologies) Recent Developments
    11.3 Virbac
        11.3.1 Virbac Company Information
        11.3.2 Virbac Overview
        11.3.3 Virbac Oral Rabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
        11.3.4 Virbac Oral Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Virbac Recent Developments

 12 Industry Chain and Sales Channels Analysis
    12.1 Oral Rabies Vaccine Industry Chain Analysis
    12.2 Oral Rabies Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Oral Rabies Vaccine Production Mode & Process
    12.4 Oral Rabies Vaccine Sales and Marketing
        12.4.1 Oral Rabies Vaccine Sales Channels
        12.4.2 Oral Rabies Vaccine Distributors
    12.5 Oral Rabies Vaccine Customers

 13 Market Dynamics
    13.1 Oral Rabies Vaccine Industry Trends
    13.2 Oral Rabies Vaccine Market Drivers
    13.3 Oral Rabies Vaccine Market Challenges
    13.4 Oral Rabies Vaccine Market Restraints

 14 Key Findings in The Global Oral Rabies Vaccine Study

 15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details

Table of Figures

List of Tables
    Table 1. Global Oral Rabies Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Table 2. Major Manufacturers of Modified Live Virus
    Table 3. Major Manufacturers of Recombinant Vaccinia
    Table 4. Major Manufacturers of Recombinant Adenovirus Vaccine
    Table 5. Global Oral Rabies Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Table 6. Global Oral Rabies Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. Global Oral Rabies Vaccine Revenue by Region (2018-2023) & (US$ Million)
    Table 8. Global Oral Rabies Vaccine Revenue by Region (2024-2029) & (US$ Million)
    Table 9. Global Oral Rabies Vaccine Revenue Market Share by Region (2018-2023)
    Table 10. Global Oral Rabies Vaccine Revenue Market Share by Region (2024-2029)
    Table 11. Global Oral Rabies Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 12. Global Oral Rabies Vaccine Sales by Region (2018-2023) & (K Units)
    Table 13. Global Oral Rabies Vaccine Sales by Region (2024-2029) & (K Units)
    Table 14. Global Oral Rabies Vaccine Sales Market Share by Region (2018-2023)
    Table 15. Global Oral Rabies Vaccine Sales Market Share by Region (2024-2029)
    Table 16. Global Oral Rabies Vaccine Sales by Manufacturers (2018-2023) & (K Units)
    Table 17. Global Oral Rabies Vaccine Sales Share by Manufacturers (2018-2023)
    Table 18. Global Oral Rabies Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
    Table 19. Global Oral Rabies Vaccine Revenue Share by Manufacturers (2018-2023)
    Table 20. Global Key Players of Oral Rabies Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
    Table 21. Oral Rabies Vaccine Price by Manufacturers 2018-2023 (US$/Unit)
    Table 22. Global Oral Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Oral Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Rabies Vaccine as of 2022)
    Table 24. Global Key Manufacturers of Oral Rabies Vaccine, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Oral Rabies Vaccine, Product Offered and Application
    Table 26. Global Key Manufacturers of Oral Rabies Vaccine, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Oral Rabies Vaccine Sales by Type (2018-2023) & (K Units)
    Table 29. Global Oral Rabies Vaccine Sales by Type (2024-2029) & (K Units)
    Table 30. Global Oral Rabies Vaccine Sales Share by Type (2018-2023)
    Table 31. Global Oral Rabies Vaccine Sales Share by Type (2024-2029)
    Table 32. Global Oral Rabies Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 33. Global Oral Rabies Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 34. Global Oral Rabies Vaccine Revenue Share by Type (2018-2023)
    Table 35. Global Oral Rabies Vaccine Revenue Share by Type (2024-2029)
    Table 36. Oral Rabies Vaccine Price by Type (2018-2023) & (US$/Unit)
    Table 37. Global Oral Rabies Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
    Table 38. Global Oral Rabies Vaccine Sales by Application (2018-2023) & (K Units)
    Table 39. Global Oral Rabies Vaccine Sales by Application (2024-2029) & (K Units)
    Table 40. Global Oral Rabies Vaccine Sales Share by Application (2018-2023)
    Table 41. Global Oral Rabies Vaccine Sales Share by Application (2024-2029)
    Table 42. Global Oral Rabies Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 43. Global Oral Rabies Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 44. Global Oral Rabies Vaccine Revenue Share by Application (2018-2023)
    Table 45. Global Oral Rabies Vaccine Revenue Share by Application (2024-2029)
    Table 46. Oral Rabies Vaccine Price by Application (2018-2023) & (US$/Unit)
    Table 47. Global Oral Rabies Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
    Table 48. US & Canada Oral Rabies Vaccine Sales by Type (2018-2023) & (K Units)
    Table 49. US & Canada Oral Rabies Vaccine Sales by Type (2024-2029) & (K Units)
    Table 50. US & Canada Oral Rabies Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 51. US & Canada Oral Rabies Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 52. US & Canada Oral Rabies Vaccine Sales by Application (2018-2023) & (K Units)
    Table 53. US & Canada Oral Rabies Vaccine Sales by Application (2024-2029) & (K Units)
    Table 54. US & Canada Oral Rabies Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 55. US & Canada Oral Rabies Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 56. US & Canada Oral Rabies Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 57. US & Canada Oral Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 58. US & Canada Oral Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 59. US & Canada Oral Rabies Vaccine Sales by Country (2018-2023) & (K Units)
    Table 60. US & Canada Oral Rabies Vaccine Sales by Country (2024-2029) & (K Units)
    Table 61. Europe Oral Rabies Vaccine Sales by Type (2018-2023) & (K Units)
    Table 62. Europe Oral Rabies Vaccine Sales by Type (2024-2029) & (K Units)
    Table 63. Europe Oral Rabies Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 64. Europe Oral Rabies Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 65. Europe Oral Rabies Vaccine Sales by Application (2018-2023) & (K Units)
    Table 66. Europe Oral Rabies Vaccine Sales by Application (2024-2029) & (K Units)
    Table 67. Europe Oral Rabies Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 68. Europe Oral Rabies Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 69. Europe Oral Rabies Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 70. Europe Oral Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 71. Europe Oral Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 72. Europe Oral Rabies Vaccine Sales by Country (2018-2023) & (K Units)
    Table 73. Europe Oral Rabies Vaccine Sales by Country (2024-2029) & (K Units)
    Table 74. China Oral Rabies Vaccine Sales by Type (2018-2023) & (K Units)
    Table 75. China Oral Rabies Vaccine Sales by Type (2024-2029) & (K Units)
    Table 76. China Oral Rabies Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 77. China Oral Rabies Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 78. China Oral Rabies Vaccine Sales by Application (2018-2023) & (K Units)
    Table 79. China Oral Rabies Vaccine Sales by Application (2024-2029) & (K Units)
    Table 80. China Oral Rabies Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 81. China Oral Rabies Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 82. Asia Oral Rabies Vaccine Sales by Type (2018-2023) & (K Units)
    Table 83. Asia Oral Rabies Vaccine Sales by Type (2024-2029) & (K Units)
    Table 84. Asia Oral Rabies Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 85. Asia Oral Rabies Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 86. Asia Oral Rabies Vaccine Sales by Application (2018-2023) & (K Units)
    Table 87. Asia Oral Rabies Vaccine Sales by Application (2024-2029) & (K Units)
    Table 88. Asia Oral Rabies Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 89. Asia Oral Rabies Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 90. Asia Oral Rabies Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 91. Asia Oral Rabies Vaccine Revenue by Region (2018-2023) & (US$ Million)
    Table 92. Asia Oral Rabies Vaccine Revenue by Region (2024-2029) & (US$ Million)
    Table 93. Asia Oral Rabies Vaccine Sales by Region (2018-2023) & (K Units)
    Table 94. Asia Oral Rabies Vaccine Sales by Region (2024-2029) & (K Units)
    Table 95. Middle East, Africa and Latin America Oral Rabies Vaccine Sales by Type (2018-2023) & (K Units)
    Table 96. Middle East, Africa and Latin America Oral Rabies Vaccine Sales by Type (2024-2029) & (K Units)
    Table 97. Middle East, Africa and Latin America Oral Rabies Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Oral Rabies Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Oral Rabies Vaccine Sales by Application (2018-2023) & (K Units)
    Table 100. Middle East, Africa and Latin America Oral Rabies Vaccine Sales by Application (2024-2029) & (K Units)
    Table 101. Middle East, Africa and Latin America Oral Rabies Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Oral Rabies Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Oral Rabies Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 104. Middle East, Africa and Latin America Oral Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Oral Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Oral Rabies Vaccine Sales by Country (2018-2023) & (K Units)
    Table 107. Middle East, Africa and Latin America Oral Rabies Vaccine Sales by Country (2024-2029) & (K Units)
    Table 108. Boehringer Ingelheim(Merial) Company Information
    Table 109. Boehringer Ingelheim(Merial) Description and Major Businesses
    Table 110. Boehringer Ingelheim(Merial) Oral Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 111. Boehringer Ingelheim(Merial) Oral Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Boehringer Ingelheim(Merial) Recent Developments
    Table 113. Ceva Santé Animale(Artemis Technologies) Company Information
    Table 114. Ceva Santé Animale(Artemis Technologies) Description and Major Businesses
    Table 115. Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 116. Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Ceva Santé Animale(Artemis Technologies) Recent Developments
    Table 118. Virbac Company Information
    Table 119. Virbac Description and Major Businesses
    Table 120. Virbac Oral Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 121. Virbac Oral Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Virbac Recent Developments
    Table 123. Key Raw Materials Lists
    Table 124. Raw Materials Key Suppliers Lists
    Table 125. Oral Rabies Vaccine Distributors List
    Table 126. Oral Rabies Vaccine Customers List
    Table 127. Oral Rabies Vaccine Market Trends
    Table 128. Oral Rabies Vaccine Market Drivers
    Table 129. Oral Rabies Vaccine Market Challenges
    Table 130. Oral Rabies Vaccine Market Restraints
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oral Rabies Vaccine Product Picture
    Figure 2. Global Oral Rabies Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Oral Rabies Vaccine Market Share by Type in 2022 & 2029
    Figure 4. Modified Live Virus Product Picture
    Figure 5. Recombinant Vaccinia Product Picture
    Figure 6. Recombinant Adenovirus Vaccine Product Picture
    Figure 7. Global Oral Rabies Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 8. Global Oral Rabies Vaccine Market Share by Application in 2022 & 2029
    Figure 9. Government
    Figure 10. Commercial
    Figure 11. Oral Rabies Vaccine Report Years Considered
    Figure 12. Global Oral Rabies Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Oral Rabies Vaccine Revenue 2018-2029 (US$ Million)
    Figure 14. Global Oral Rabies Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
    Figure 15. Global Oral Rabies Vaccine Revenue Market Share by Region (2018-2029)
    Figure 16. Global Oral Rabies Vaccine Sales 2018-2029 ((K Units)
    Figure 17. Global Oral Rabies Vaccine Sales Market Share by Region (2018-2029)
    Figure 18. US & Canada Oral Rabies Vaccine Sales YoY (2018-2029) & (K Units)
    Figure 19. US & Canada Oral Rabies Vaccine Revenue YoY (2018-2029) & (US$ Million)
    Figure 20. Europe Oral Rabies Vaccine Sales YoY (2018-2029) & (K Units)
    Figure 21. Europe Oral Rabies Vaccine Revenue YoY (2018-2029) & (US$ Million)
    Figure 22. China Oral Rabies Vaccine Sales YoY (2018-2029) & (K Units)
    Figure 23. China Oral Rabies Vaccine Revenue YoY (2018-2029) & (US$ Million)
    Figure 24. Asia (excluding China) Oral Rabies Vaccine Sales YoY (2018-2029) & (K Units)
    Figure 25. Asia (excluding China) Oral Rabies Vaccine Revenue YoY (2018-2029) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Oral Rabies Vaccine Sales YoY (2018-2029) & (K Units)
    Figure 27. Middle East, Africa and Latin America Oral Rabies Vaccine Revenue YoY (2018-2029) & (US$ Million)
    Figure 28. The Oral Rabies Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
    Figure 29. The Top 5 and 10 Largest Manufacturers of Oral Rabies Vaccine in the World: Market Share by Oral Rabies Vaccine Revenue in 2022
    Figure 30. Global Oral Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 31. Global Oral Rabies Vaccine Sales Market Share by Type (2018-2029)
    Figure 32. Global Oral Rabies Vaccine Revenue Market Share by Type (2018-2029)
    Figure 33. Global Oral Rabies Vaccine Sales Market Share by Application (2018-2029)
    Figure 34. Global Oral Rabies Vaccine Revenue Market Share by Application (2018-2029)
    Figure 35. US & Canada Oral Rabies Vaccine Sales Market Share by Type (2018-2029)
    Figure 36. US & Canada Oral Rabies Vaccine Revenue Market Share by Type (2018-2029)
    Figure 37. US & Canada Oral Rabies Vaccine Sales Market Share by Application (2018-2029)
    Figure 38. US & Canada Oral Rabies Vaccine Revenue Market Share by Application (2018-2029)
    Figure 39. US & Canada Oral Rabies Vaccine Revenue Share by Country (2018-2029)
    Figure 40. US & Canada Oral Rabies Vaccine Sales Share by Country (2018-2029)
    Figure 41. U.S. Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 42. Canada Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 43. Europe Oral Rabies Vaccine Sales Market Share by Type (2018-2029)
    Figure 44. Europe Oral Rabies Vaccine Revenue Market Share by Type (2018-2029)
    Figure 45. Europe Oral Rabies Vaccine Sales Market Share by Application (2018-2029)
    Figure 46. Europe Oral Rabies Vaccine Revenue Market Share by Application (2018-2029)
    Figure 47. Europe Oral Rabies Vaccine Revenue Share by Country (2018-2029)
    Figure 48. Europe Oral Rabies Vaccine Sales Share by Country (2018-2029)
    Figure 49. Germany Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 50. France Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 51. U.K. Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 52. Italy Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 53. Russia Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 54. China Oral Rabies Vaccine Sales Market Share by Type (2018-2029)
    Figure 55. China Oral Rabies Vaccine Revenue Market Share by Type (2018-2029)
    Figure 56. China Oral Rabies Vaccine Sales Market Share by Application (2018-2029)
    Figure 57. China Oral Rabies Vaccine Revenue Market Share by Application (2018-2029)
    Figure 58. Asia Oral Rabies Vaccine Sales Market Share by Type (2018-2029)
    Figure 59. Asia Oral Rabies Vaccine Revenue Market Share by Type (2018-2029)
    Figure 60. Asia Oral Rabies Vaccine Sales Market Share by Application (2018-2029)
    Figure 61. Asia Oral Rabies Vaccine Revenue Market Share by Application (2018-2029)
    Figure 62. Asia Oral Rabies Vaccine Revenue Share by Region (2018-2029)
    Figure 63. Asia Oral Rabies Vaccine Sales Share by Region (2018-2029)
    Figure 64. Japan Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 65. South Korea Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 66. China Taiwan Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 67. Southeast Asia Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 68. India Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Oral Rabies Vaccine Sales Market Share by Type (2018-2029)
    Figure 70. Middle East, Africa and Latin America Oral Rabies Vaccine Revenue Market Share by Type (2018-2029)
    Figure 71. Middle East, Africa and Latin America Oral Rabies Vaccine Sales Market Share by Application (2018-2029)
    Figure 72. Middle East, Africa and Latin America Oral Rabies Vaccine Revenue Market Share by Application (2018-2029)
    Figure 73. Middle East, Africa and Latin America Oral Rabies Vaccine Revenue Share by Country (2018-2029)
    Figure 74. Middle East, Africa and Latin America Oral Rabies Vaccine Sales Share by Country (2018-2029)
    Figure 75. Brazil Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 76. Mexico Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 77. Turkey Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 78. Israel Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 79. GCC Countries Oral Rabies Vaccine Revenue (2018-2029) & (US$ Million)
    Figure 80. Oral Rabies Vaccine Value Chain
    Figure 81. Oral Rabies Vaccine Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed

Description

Global Oral Rabies Vaccine market is expected to reach to US$ 98 million in 2023, with a positive growth of %, compared with US$ 80 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Oral Rabies Vaccine industry is evaluated to reach US$ 297 million in 2029. The CAGR will be 20.3% during 2023 to 2029.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:
This report presents an overview of global Oral Rabies Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Oral Rabies Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted. 
Manufacturers, Type, Application and Regions Listed in the Report:

Chapter Outline
Chapter 1: Product definition, type and application introduction
Chapter 2: Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3: Manufacturers’ sales, revenue and price analysis, including manufacturers’ Oral Rabies Vaccine plant distribution, commercial date of Oral Rabies Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4: Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5: Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6: Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7: Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8: Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9: Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10: Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11: Manufacturers’ outline, covering company’s basic information, major business, Oral Rabies Vaccine introduction, etc. Oral Rabies Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12: Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13: Market opportunities and challenges analysis
Chapter 14: QYResearch’s Conclusions of Oral Rabies Vaccine
Chapter 15: Methodology and Data Sources adopted by QYResearch

Industry: Pharma & Healthcare

Published: 2023-08-28

Pages: 77 Pages

Report ld: 1632783

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 4900.00

Multi Users License

USD 7350.00

Corporate Users License